| Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells E Curry, I Green, N Chapman-Rothe, E Shamsaei, S Kandil, FL Cherblanc, ... Clinical epigenetics 7, 1-12, 2015 | 72 | 2015 |
| Perspectives on natural product epigenetic modulators in chemical biology and medicine FL Cherblanc, RWM Davidson, P Di Fruscia, N Srimongkolpithak, ... Natural Product Reports 30 (5), 605-624, 2013 | 63 | 2013 |
| Identification of 2, 4-diamino-6, 7-dimethoxyquinoline derivatives as G9a inhibitors N Srimongkolpithak, S Sundriyal, F Li, M Vedadi, MJ Fuchter MedChemComm 5 (12), 1821-1828, 2014 | 40 | 2014 |
| Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood‐stage antimalarial compounds S Sundriyal, NA Malmquist, J Caron, S Blundell, F Liu, X Chen, ... ChemMedChem 9 (10), 2360-2373, 2014 | 39 | 2014 |
| Semi-Synthesis of N-Aryl Amide Analogs of Piperine from Piper nigrum and Evaluation of Their Antitrypanosomal, Antimalarial, and Anti-SARS-CoV-2 Main … R Wansri, ACK Lin, J Pengon, S Kamchonwongpaisan, ... Molecules 27 (9), 2841, 2022 | 12 | 2022 |
| Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening M Hoarau, J Vanichtanankul, N Srimongkolpithak, D Vitsupakorn, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 198-206, 2021 | 8 | 2021 |
| Discovery of a Multifunctional Octapeptide from Lingzhi with Antioxidant and Tyrosinase Inhibitory Activity Y Yingchutrakul, S Krobthong, K Choowongkomon, P Papan, P Samutrtai, ... Pharmaceuticals 15 (6), 684, 2022 | 7 | 2022 |
| Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells. Clin Epigenetics 7: 84 E Curry, I Green, N Chapman-Rothe, E Shamsaei, S Kandil, FL Cherblanc, ... | 7 | 2015 |
| 5-phenoxy primaquine analogs and the tetraoxane hybrid as antimalarial agents S Jansongsaeng, N Srimongkolpithak, J Pengon, S Kamchonwongpaisan, ... Molecules 26 (13), 3991, 2021 | 6 | 2021 |
| Scalable synthesis of favipiravir via conventional and continuous flow chemistry T Tiyasakulchai, N Charoensetakul, T Khamkhenshorngphanuch, ... RSC advances 11 (61), 38691-38693, 2021 | 6 | 2021 |
| N-Containing α-Mangostin Analogs via Smiles Rearrangement as the Promising Cytotoxic, Antitrypanosomal, and SARS-CoV-2 Main Protease Inhibitory Agents NYL Pyae, A Maiuthed, W Phongsopitanun, B Ouengwanarat, W Sukma, ... Molecules 28 (3), 1104, 2023 | 2 | 2023 |
| 554 Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells R Brown, M Fuchter, E Curry, I Green, S Kandil, F Cherblanc, L Payne, ... European Journal of Cancer, 179-180, 2014 | 1 | 2014 |
| Enhancement of intestinal calcium transport by short-chain fatty acids: roles of Na+/H+ exchanger 3 and transient receptor potential vanilloid subfamily 6 N Thammayon, K Wongdee, J Teerapornpuntakit, J Panmanee, ... American Journal of Physiology-Cell Physiology 326 (2), C317-C330, 2024 | | 2024 |
| Development of a Practical Synthetic Method for Clinical Candidate 3-(2-{3-[(2, 4-Diamino-6-ethylpyrimidin-5-yl) oxy] propoxy} phenyl) propanoic acid (P218) and Its … O Vorasin, T Phumjan, S Saepua, D Iwaniuk, S Kamchonwongpaisan, ... Synthesis 55 (23), 3947-3953, 2023 | | 2023 |
| Quinazoline compounds and their use in therapy R Brown, MJ Fuchter, N Chapman-Rothe, N Srimongkolpithak, J Caron, ... US Patent 9,932,317, 2018 | | 2018 |
| The search for novel histone lysine methyltransferase inhibitors N Srimongkolpithak Imperial College London, 2015 | | 2015 |
| DISCOVERY OF NOVEL CHOLINESTERASE INHIBITOR (RKNU026) WITH p-AMYLOID AGGREGATION INHIBITORY ACTIVITY T Hiranyaekaphap, N Srimongkolpithak, T Wongchang, ... The Thai Journal of Pharmaceutical Sciences 38, 4-7, 2013 | | 2013 |
| Favipiravir ProTides: Enhancing Antiviral Efficiency Against Various Viruses T Tiyasakulchai, T Uengwetwanit, P Jaru-ampornpan, J Narkpuk, ... | | |
